PAA 2.33% 21.0¢ pharmaust limited

Clinical Trials Interview June 2022, page-3

  1. 8,827 Posts.
    lightbulb Created with Sketch. 1711
    Other then Roger saying the paperwork is finished nothing new in this interview.
    Not sure if others got anything else out of it.
    Discussion still in early stages, this has been the same over the last few years but never seems to progress beyond early stages
    And didn't they report sometime ago about starting discussions with the FDA
    Haven't we had good data from canine trials for two years but we are still in phrase 2 trial doing a small pilot trial in US, isn't a pilot trial by definition a small trial.
    Over a number of announcements its been stated that dog recruitment continues in Australia and NZ but we never hear of these dogs.
    It took them 0ver 5 months to recruit and trial one dog in NZ and other then report the trial went well nothing really more.
    If I was a new investor nothing in that interview would spark much interest
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
-0.005(2.33%)
Mkt cap ! $93.45M
Open High Low Value Volume
21.0¢ 21.5¢ 21.0¢ $85.73K 407.4K

Buyers (Bids)

No. Vol. Price($)
2 53482 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 278844 4
View Market Depth
Last trade - 15.15pm 19/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.